Accipiter Biosciences vs Treeline Biosciences
Which Drug Discovery AI tool is better in 2026?
Accipiter Biosciences
AI-designed de novo protein therapies for complex diseases
Treeline Biosciences
Computational and experimental drug discovery for hard-to-drug cancer targets
Side-by-side
Treeline Biosciences is the more established option (raised $1.1B); pricing is comparable on both sides.
| Metric | Accipiter Biosciences | Treeline Biosciences |
|---|---|---|
| Taglinei | AI-designed de novo protein therapies for complex diseases | Computational and experimental drug discovery for hard-to-drug cancer targets |
| Foundedi | 2025 | 2021🏆 |
| HQi | Seattle, United States | Stamford, US |
| Employeesi | — | 201-500🏆 |
| Neuron scorei | 68 | 82🏆 |
| Total fundingi | $12.7M | $1.1B🏆 |
| Latest roundi | Seed · Nov 2025 | Series A · Aug 2025 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Accipiter Biosciences and Treeline Biosciences.
| Capability | Accipiter Biosciences | Treeline Biosciences |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Accipiter Biosciences
- Newer company (2025)
🔵 Strengths of Treeline Biosciences
- Has raised more capital ($1.1B vs $12.7M)
- Higher Neuron score (82 vs 68)
- More mature (2021)
Which should you choose?
Choose Treeline Biosciences if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Treeline Biosciences if you want the most established option — it has raised $1.1B, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Accipiter Biosciences vs Treeline Biosciences — which is better?
It depends on your priority. Accipiter Biosciences is the leaner option; Treeline Biosciences has broader feature depth. See the side-by-side table above.
Is Accipiter Biosciences cheaper than Treeline Biosciences?
No — Treeline Biosciences's cheapest paid plan is Enterprise · Contact sales, while Accipiter Biosciences's is Custom.
Do Accipiter Biosciences and Treeline Biosciences offer free plans?
Accipiter Biosciences: Paid only. Treeline Biosciences: Paid only.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.